Good Evening Market Enthusiast,
Â
There’s a name you’ve seen before.
Â
And it’s back—not with chatter, but with checks.
Â
This one exploded +95% in early 2025. It had the science, the setup, the buzz.
Â
Now the gears are turning again: bigger backing, visible milestones, accelerated timelines.
Â
Full reveal
drops tomorrow at 8AM EST.
Â
In the last few weeks:
• A major federal agency funded U.S. trial enrollment
• The FDA granted Fast Track—a rare edge in oncology
• A $2.25M raise closed to kick off the next step
• And a follow-on $736.6K placement added more fuel
Â
This isn’t a pivot—it’s a pressure cooker.
Â
A telomere-targeting approach
designed to re-ignite immune response in patients who’ve already failed chemo and checkpoint inhibitors—with survival signals that are drawing attention.
Â
Backed by federal dollars. Fast-tracked. Now funded to move.
Last time, it caught people off guard.
Â
This time, you’re early.
Â
Tight float. Data sharpening. Funding
landed.
Â
📎 Watch your inbox at 8AM EST.
Â
Max Masters
Co-founder, Market Tips Newsletter
Â